Vermillion's Category 1 CPT Application Approved

The American Medical Association Current Procedural Terminology Panel approved Vermillion Inc.'s (Nasdaq: VRML) Category 1 CPT code application for its OVA1 test to differentiate benign versus malignant ovarian masses. The stock price more than doubled by jumping $1.67 to close at $3.00.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here